Home
Meet our team

Meet our team

AxTalis is a team of dedicated professionals to support or integrate with your Regulatory Affairs, Market Access, and Medical Affairs team.

More about each one of us...

With 20 years of commercial and market access experience, Sven leverages an extensive network of stakeholders and is intimately familiar with influencers and decision makers for access to innovation.

Sven Tops

Chief Market Access Officer

Sofie is a pharmacist by education with an MBA. Her broad and scientific background enables her to have a quick and in-depth understanding of the mechanisms of diseases and medicines.

Sofie Vermander

Senior Medical Manager

Frank is an experienced pharma executive focusing on strategy and patient value. Based on analysis and insights, he loves to develop medico-marketing projects throughout the product lifecycle.

Frank Vanderdonck

Chief Medical Officer

A chemist by education, Monica completed her PhD at the KU Leuven. Restless curiosity drove her to explore electrochemistry, spectroscopy and nanomaterials applied to life sciences.

Monica Ricci

Senior Medical & Market Access Manager

A Medical Doctor by training, Nele brings a decade of clinical and medical affairs experience to AxTalis with a focus on patient care and rare diseases.

Nele Stichelbaut

Medical & Market Access Manager

Louise is a pharmacist with a master in drug development. A medical information and pharmacovigilance expert, she is a go-to contact for clinicians, pharmacists, and patients.

Louise Vandevelde

Medical Manager

Melanie has more than 20 years market access experience, both in Dutch and global teams, in pharma & medical devices. Based in the Netherlands she is fully dedicated to support the Dutch market.

Melanie van Riemsdijk

Director Market Access Benelux

With a PhD in viral evolution and epidemiology, and gained business experience in software development, Kristof leverages data modelling (R, Python) to accelerate market access and HEOR projects.

Kristof Theys

Health Economics & Data Science Manager

Domien is a pharmacist with a master in drug development. Passionate about innovation in therapeutic approaches and patient care, he brings expertise in mHealth and digital health policy to AxTalis.

Domien Verdonck

Regulatory Affairs Officer

Maud is a second year master student in drug development and is currently fulfilling her internship at AxTalis.

Maud Brijs

Intern

Wim is an experienced Regulatory Affairs professional. After spending more than 10 years in different pharma companies, he decided to move to consulting to support clients on all regulatory matters.

Wim Neckebroeck

Director Regulatory Affairs

Chloe is a highly organized and detail-oriented individual with a passion for problem-solving. She can be counted on to be the rock in the surf when things get tough.

Chloe De Bruyne

Management Assistant

As a pharmacist and with a PhD in infectious diseases, Marlies tackles medical and market access projects with rigor and precision, based on profound analysis and relentless curiosity.

Marlies Boeren

Senior Medical & Market Access Manager

Sabrina is a pharmacist with a Master degree in drug development. She brings Regulatory Affairs expertise to AxTalis and is dedicated to high-quality support for clients on all regulatory matters.

Sabrina Lagniau

Regulatory Affairs Officer

Marieke Schurer, has over 9 years of experience in HTA-related evidence generation and validation, Marieke excels in qualitative research, always advocating for patient perspectives.

Marieke Schurer

Medical & Market Access Manager

Brently Berx

Medical Affairs Officer

Prior to transitioning into tech and working at MAP, Daniel worked in the Design & Animation industry as a motion designer. He helped brands communicate their message to the public through animation and visual storytelling. He worked with brands across the world, most notable ones being Saturday Night Live & Youtube Music.

Daniel Capra

IT Support Associate

Sam has over 20 years of experience of drug development in the biotechnology and pharmaceutical sector of which over 12 years in Regulatory Affairs. Sam has a track record of successfully leading regulatory interactions in support of clinical development of innovative products, including most recently for a cell therapy ATMP at Cellaïon SA.

Sam Bryant

Regulatory Affairs Manager